GL1X · GenesisL1 explorer

UniProt F7X6I3

Bifunctional protein PutA (F7X6I3)

Bifunctional protein PutA (UniProt F7X6I3), EC 1.2.1.88, 1.5.5.2: 49 experimental structures on GenesisL1, 38 ligands bound, 599 pockets. Binding sites, pockets, druggability and 3D structures in GL1X.

UniProt
F7X6I3
Protein
Bifunctional protein PutA
EC
1.2.1.88, 1.5.5.2
Experimental structures
49
Predicted models
0
Ligands
38
Pockets
599 · 35 records with a druggable one

Structures

49 records of F7X6I3 in the MolNFT archive: 49 experimental, 0 predicted.

EntryTitleMethodChainsLigandsPockets
5KF6Structure of proline utilization A from Sinorhizobium meliloti complexed with L-tetrahydrofuroic…x-ray diffractionA, BFAD, NAD, TFB—
5KF6Structure of proline utilization a from sinorhizobium meliloti complexed with L-tetrahydrofuroic…x-ray diffractionA, BFAD, NAD, TFB—
5KF7Structure of proline utilization A from Sinorhizobium meliloti complexed with L-tetrahydrofuroic…x-ray diffractionAFAD, NAD, TFB, SO4, MG16 (best 0.87)
5KF7Structure of proline utilization a from sinorhizobium meliloti complexed with L-tetrahydrofuroic…x-ray diffractionAFAD, NAD, TFB, SO4—
6UFPStructure of proline utilization A with the FAD covalently modified by L-thiazolidine-2-carboxylate…x-ray diffractionA, BFDA, T2C, NAD, SO420 (best 0.86)
6UFPStructure of proline utilization a with the FAD covalently modified by L-thiazolidine-2-carboxylate…x-ray diffractionA, BFDA, T2C, NAD, SO4—
6VZ9Structure of proline utilization A with the FAD covalently modified by L-thiazolidine-2-carboxylatex-ray diffractionA, BFAD, NAD, MG, T2C, SO420 (best 0.87)
6VZ9Structure of proline utilization a with the FAD covalently modified by L-thiazolidine-2-carboxylatex-ray diffractionA, BFAD, NAD, T2C, SO4—
6X99Structure of proline utilization A with D-proline bound in the L-glutamate-gamma-semialdehyde…x-ray diffractionA, BFAD, SO4, DPR20 (best 0.87)
6X99Structure of proline utilization a with D-proline bound in the L- glutamate-gamma-semialdehyde…x-ray diffractionA, BFAD, SO4—
6X9AStructure of proline utilization A with trans-4-hydroxy-D-proline bound in the…x-ray diffractionA, BFAD, UY7, SO420 (best 0.87)
6X9AStructure of proline utilization a with trans-4-hydroxy-D-proline bound in the…x-ray diffractionA, BFAD, SO4—
6X9BStructure of proline utilization A with cis-4-hydroxy-D-proline bound in the…x-ray diffractionA, BFAD, NAD, SO4, UYA20 (best 0.87)
6X9BStructure of proline utilization a with cis-4-hydroxy-D-proline bound in the…x-ray diffractionA, BFAD, NAD, SO4—
6X9CStructure of proline utilization A with L-proline bound in the L-glutamate-gamma-semialdehyde…x-ray diffractionA, BNAI, FDA, SO4, MG, PRO20 (best 0.84)
6X9CStructure of proline utilization a with L-proline bound in the L- glutamate-gamma-semialdehyde…x-ray diffractionA, BNAI, FDA, SO4—
6X9DStructure of proline utilization A with trans-4-hydroxy-L-proline bound in the…x-ray diffractionA, BFAD, HYP, NAD, SO4, MG20 (best 0.87)
6X9DStructure of proline utilization a with trans-4-hydroxy-L-proline bound in the…x-ray diffractionA, BFAD, NAD, SO4—
7MY9Structure of proline utilization A with 1,3-dithiolane-2-carboxylate bound in the proline…x-ray diffractionA, BUJD, FAD, NAD, SO4, MG20 (best 0.87)
7MY9Structure of proline utilization a with 1,3-dithiolane-2-carboxylate bound in the proline…x-ray diffractionA, BUJD, FAD, NAD, SO4—
7MYAStructure of proline utilization A with the FAD covalently-modified by 1,3-dithiolanex-ray diffractionA, BUJJ, MG, NAD, SO420 (best 0.86)
7MYAStructure of proline utilization a with the FAD covalently-modified by 1,3-dithiolanex-ray diffractionA, BUJJ, NAD, SO4—
7MYBStructure of proline utilization A with tetrahydrothiophene-2-carboxylate bound in the proline…x-ray diffractionA, BUJM, UJP, FAD, NAD, SO4, MG20 (best 0.88)
7MYBStructure of proline utilization a with tetrahydrothiophene-2- carboxylate bound in the proline…x-ray diffractionA, BUJM, UJP, FAD, NAD, SO4—
7MYCStructure of proline utilization A with the FAD covalently modified by tetrahydrothiophenex-ray diffractionA, BUJG, NAI, SO420 (best 0.86)
7MYCStructure of proline utilization a with the FAD covalently modified by tetrahydrothiophenex-ray diffractionA, BUJG, NAI, SO4—
8DKOMinimal PutA proline dehydrogenase domain (design #1) complexed with S-(-)-tetrahydro-2-furoic acidx-ray diffractionA, BFAD, TFB11 (best 0.83)
8DKPMinimal PutA proline dehydrogenase domain (design #2) complexed with S-(-)-tetrahydro-2-furoic acidx-ray diffractionA, BFAD, TFB8 (best 0.84)
8DKQMinimal PutA proline dehydrogenase domain (design #2) complexed with 2-(Furan-2-yl)acetic acidx-ray diffractionA, BFAD, SJU9 (best 0.84)
8UPZMinimal PutA proline dehydrogenase domain (design #2) complexed with (Prop-2-ynylthio)acetic acidx-ray diffractionA, BFAD, X798 (best 0.84)
8UQ0Minimal PutA proline dehydrogenase domain (design #2) complexed with 2-(Cyanomethylthio)acetic acidx-ray diffractionA, BFAD, X7K9 (best 0.84)
8UQ1Minimal PutA proline dehydrogenase domain (design #2) complexed with (Allylthio)acetic acidx-ray diffractionA, BFAD, X7Q10 (best 0.84)
8W0KMinimal PutA proline dehydrogenase domain (design #2) complexed with 1-hydroxyethane-1-sulfonatex-ray diffractionA, BFAD, GHO9 (best 0.81)
9C8AMinimal PutA proline dehydrogenase domain (design #2) with the FAD N5 modified with propanal…x-ray diffractionA, BFDA, FAD, CBG10 (best 0.83)
9C8BMinimal PutA proline dehydrogenase domain (design #2) with the FAD N5 modified with propanal…x-ray diffractionA, BFDA, FAD, CBG9 (best 0.83)
9C8CStructure of proline utilization A with the FAD covalently-modified by propanal resulting from…x-ray diffractionA, BFDA, CBG, NAD, MG, SO4, A1AV820 (best 0.84)
9DL2Structure of proline utilization A complexed with 2,3-dihydro-1,4-benzodioxine-5-carboxylic acidx-ray diffractionA, BFAD, 53E, NAD, SO4, MG20 (best 0.87)
9DL3Structure of proline utilization A complexed with quinoline-2-carboxylic acidx-ray diffractionA, BFAD, QNC, SO4, MG20 (best 0.85)
9DL4Structure of proline utilization A complexed with 2-pyridinethiolx-ray diffractionA, BPYS, SO4, FAD20 (best 0.84)
9DL5Structure of proline utilization A complexed with 5-chloro-1-indax-ray diffractionA, BFAD, A1BDA, SO420 (best 0.84)
9DL6Structure of proline utilization A complexed with piperidine-3-carboxylic acidx-ray diffractionA, BFAD, A1BDB, ID7, SO4, NAD, MG20 (best 0.86)
9DL7Structure of proline utilization A complexed with 1-(4-fluorophenyl)thioureax-ray diffractionA, BFAD, 8P4, SO420 (best 0.85)
9DL8Structure of proline utilization A soaked with 4-methoxybenzyl alcoholx-ray diffractionA, BFAD, A1BDD, NAD, SO420 (best 0.86)
9DL9Structure of proline utilization A co-crystallized with 4-methoxybenzyl alcoholx-ray diffractionA, BFAD, A1BDD, NAD, SO4, MG20 (best 0.87)
9E0AStructure of proline utilization A complexed with 1,4-benzenedimethanolx-ray diffractionA, BFAD, NAD, SO4, MG, A1BDW20 (best 0.87)
9E0BStructure of proline utilization A complexed with (2,3-dihydro-1-benzofuran-5-yl)methanolx-ray diffractionA, BFAD, A1AQC, NAD, SO4, MG20 (best 0.87)
9E0CStructure of proline utilization A complexed with 1-benzofuran-5-ylmethanolx-ray diffractionA, BFAD, A1BDX, NAD, SO4, MG20 (best 0.87)
9E0DStructure of proline utilization A complexed with piperonyl alcoholx-ray diffractionA, BFAD, A1BDV, NAD, SO4, MG20 (best 0.87)
9E0EStructure of proline utilization A complexed with (1H-indol-5-yl)methanolx-ray diffractionA, BFAD, A1BDU, NAD, SO4, MG20 (best 0.87)

Ligands

  • FAD · Flavin-adenine dinucleotide · in 40 records
  • SO4 · Sulfate ion · in 38 records
  • NAD · Nicotinamide-adenine-dinucleotide · in 28 records
  • MG · Magnesium ion · in 17 records
  • FDA · Dihydroflavine-adenine dinucleotide · in 7 records
  • TFB · Tetrahydrofuran-2-carboxylic acid · in 6 records
  • NAI · 1,4-dihydronicotinamide adenine dinucleotide · in 4 records
  • T2C · (2S)-1,3-thiazolidine-2-carboxylic acid · in 4 records
  • CBG · Propanal · in 3 records
  • A1BDD · (4-methoxyphenyl)methanol · in 2 records
  • UJD · 1,3-dithiolane-2-carboxylic acid · in 2 records
  • UJG · [(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl]methyl (2R,3S,4S)-5-{7, 8-dimethyl-2,4-dioxo-5-[(2R)-tetrahydrothiophen-2-yl]-1,3,4,5-tetrahydrobenzo[g]pteridin-10(2H)-yl}-2,3,4-trihydroxypentyl dihydrogen diphosphate (non-preferred name) · in 2 records
  • UJJ · [(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl]methyl (2R,3S,4S)-5-[5-(1,3-dithiolan-2-yl)-7,8-dimethyl-2,4-dioxo-1,3,4,5-tetrahydrobenzo[g]pteridin-10(2H)-yl]-2,3,4-trihydroxypentyl dihydrogen diphosphate · in 2 records
  • UJM · (2S)-thiolane-2-carboxylic acid · in 2 records
  • UJP · (2R)-thiolane-2-carboxylic acid · in 2 records
  • 53E · 2,3-dihydro-1,4-benzodioxine-5-carboxylic acid · in 1 record
  • 8P4 · 1-(4-fluorophenyl)thiourea · in 1 record
  • A1AQC · (2,3-dihydro-1-benzofuran-5-yl)methanol · in 1 record
  • A1AV8 · N-(prop-2-en-1-yl)glycine · in 1 record
  • A1BDA · 5-chloro-2,3-dihydro-1H-inden-1-one · in 1 record
  • A1BDB · (3S)-piperidine-3-carboxylic acid · in 1 record
  • A1BDU · (1H-indol-5-yl)methanol · in 1 record
  • A1BDV · (2H-1,3-benzodioxol-5-yl)methanol · in 1 record
  • A1BDW · (1,4-phenylene)dimethanol · in 1 record
  • A1BDX · (1-benzofuran-5-yl)methanol · in 1 record
  • DPR · D-proline · in 1 record
  • GHO · (1R)-1-hydroxyethane-1-sulfonic acid · in 1 record
  • HYP · 4-hydroxyproline · in 1 record
  • ID7 · (3R)-piperidine-3-carboxylic acid · in 1 record
  • PRO · Proline · in 1 record

Elsewhere

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.